RESEARCH PROGRESS ON ORAL GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES MELLITUS TYPE 2

Descargar Publicación
Bioactives and exercise synergize to modulate AMPK and inflammation Unraveling the connection: Inflammatory markers and diabetes mellitus pathogenesis